Proteogenomic investigations in CCA have identified novel isoforms of critical signaling proteins, including FGFR2 and EGFR, which are often modified in CCA and are integral to tumor growth and drug resistance [120,121]. The gene discussed is EGFR; the disease is neoplasm.